United States Biotechnology & Medical Research

Savara Inc (SVRA)

Track

Over the past 90 days, Savara Inc. experienced insider selling activity totaling approximately $4.48 million. The primary transaction involved the Chief Financial Officer, David L. Lowrance, who executed significant sales of company shares. These transactions occurred following the company's May 2026 results financiers, with the stock currently trading near the upper end of its 52-week range.
Ticker: SVRA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Savara Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 22 Jun 2026
Value US$4,264,747.43 | Price 53.06 | Shares 2,947 (+47.8%)
Sale 22 Jun 2026
Value US$2,957,286.90 | Price 354.63 | Shares 42,316 (-37.5%)
Proposed sale 22 Jun 2026
Value US$2,229,000.00 | Price 5.65 | Shares 394,528
Proposed sale 22 Jun 2026
Value US$2,229,000.00 | Price 5.65 | Shares 394,528
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-22 S Sale
3.3
Lowrance David L

Chief Financial Officer

Officer
2,947 +47.8%
53.06
US$4,264,747 		2,947 +47.8% 53.06 US$4,264,747
2026-06-22 2026-06-22 S Sale
3.3
Lowrance David L

Chief Financial Officer

Officer
42,316 -37.5%
354.63
US$2,957,287 		42,316 -37.5% 354.63 US$2,957,287
2026-06-22 2026-06-22 PrS Proposed sale
3.3
Lowrance David L

Officer

Officer
6,895
333.46
US$971,610 		6,895 333.46 US$971,610
2026-06-22 2026-06-22 PrS Proposed sale
3.3
Lowrance David L

Officer

Officer
394,528
5.65
US$2,229,000 		394,528 5.65 US$2,229,000
2025-12-19 2025-12-19 S Sale
3.5
RAMSAY DAVID A
Non-Executive Director
20,000 -0.8%
6.06
US$121,220 		20,000 -0.8% 6.06 US$121,220
2025-12-18 2025-12-18 PrS Proposed sale
3.5
RAMSAY DAVID A

Director

Non-Executive Director
20,000
6.11
US$122,200 		20,000 6.11 US$122,200
2025-06-23 2025-06-20 B Purchase
4.2
Hawkins Richard J
Non-Executive Director
48,225 +71.7%
2.04
US$98,572 		48,225 +71.7% 2.04 US$98,572
2025-06-02 2025-05-29 B Purchase
2.6
McCracken Joseph S
Non-Executive Director
10,000 +4.0%
2.08
US$20,825 		10,000 +4.0% 2.08 US$20,825
2025-04-01 2025-03-31 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
150,000 +6.3%
2.78
US$416,250 		150,000 +6.3% 2.78 US$416,250
2024-12-16 2024-12-16 PrS Proposed sale
2.8
Pauls Matthew

Director

Non-Executive Director
54,702
3.31
US$180,800 		54,702 3.31 US$180,800
2024-12-16 2024-12-16 PrS Proposed sale
4.2
Hawkins Richard J

Director

Non-Executive Director
8,000
3.29
US$26,300 		8,000 3.29 US$26,300
2024-12-16 2024-12-16 PrS Proposed sale
3.3
Lowrance David L

Officer

Officer
25,000
3.30
US$82,500 		25,000 3.30 US$82,500
2024-12-16 2024-12-16 S Sale
3.3
Lowrance David L

Chief Financial Officer

Officer
25,000 -6.2%
3.33
US$83,278 		25,000 -6.2% 3.33 US$83,278
2024-12-16 2024-12-16 S Sale
4.2
Hawkins Richard J
Non-Executive Director
8,000 -10.6%
3.32
US$26,569 		8,000 -10.6% 3.32 US$26,569
2024-12-16 2024-12-16 S Sale
2.8
Pauls Matthew

CHIEF EXECUTIVE OFFICER

Executive Director
54,702 -3.4%
3.31
US$180,828 		54,702 -3.4% 3.31 US$180,828
2024-11-20 2024-11-19 B Purchase
2.6
McCracken Joseph S
Non-Executive Director
20,000 +10.5%
2.95
US$59,072 		20,000 +10.5% 2.95 US$59,072
2024-11-18 2024-11-18 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
100,000 +4.5%
2.88
US$287,600 		100,000 +4.5% 2.88 US$287,600
2023-12-29 2023-12-28 S Sale
2.8
Pauls Matthew

CHIEF EXECUTIVE OFFICER

Executive Director
84,000 -6.1%
4.71
US$395,900 		84,000 -6.1% 4.71 US$395,900
2023-12-29 2023-12-28 S Sale
3.3
Elam Nevan C
Non-Executive Director
93,843 -80.7%
4.71
US$442,291 		93,843 -80.7% 4.71 US$442,291
2023-12-29 2023-12-28 S Sale
3.3
Lowrance David L

CHIEF FINANCIAL OFFICER

Officer
10,000 -2.8%
4.71
US$47,131 		10,000 -2.8% 4.71 US$47,131
2023-12-28 2023-12-28 PrS Proposed sale
2.8
Pauls Matthew

Officer; Director

Executive Director
84,000
4.74
US$398,000 		84,000 4.74 US$398,000
2023-12-28 2023-12-28 PrS Proposed sale
3.3
Lowrance David L

Officer

Officer
10,000
4.74
US$47,400 		10,000 4.74 US$47,400
2023-12-28 2023-12-28 PrS Proposed sale
3.3
Elam Nevan C

Director

Non-Executive Director
93,843
4.78
US$448,569 		93,843 4.78 US$448,569
2023-07-19 2023-07-17 B Purchase
2.5
BASKETT FOREST
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
2.7
Florence Anthony A. Jr.
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
1.5
Behbahani Ali
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.3
Yang Rick
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.6
Chang Carmen
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.9
Walker Paul Edward
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.3
Mathers Edward T
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
3.2
Growth Equity Opportunities 17, LLC
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-19 2023-07-17 B Purchase
2.9
Makhzoumi Mohamad
Large shareholder
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-06-27 2023-06-26 B Purchase
3.6
Pratt Raymond Dennis

Chief Medical Officer

Officer
6,500 +4.2%
2.93
US$19,045 		6,500 +4.2% 2.93 US$19,045
2023-05-26 2023-05-26 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
37,124 +1.7%
2.63
US$97,599 		37,124 +1.7% 2.63 US$97,599
2023-05-26 2023-05-25 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
12,876 +0.6%
2.57
US$33,130 		12,876 +0.6% 2.57 US$33,130
2023-05-26 2023-05-24 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
50,000 +2.4%
2.56
US$127,800 		50,000 +2.4% 2.56 US$127,800
2023-01-03 2022-12-30 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
29,000 +1.4%
1.55
US$44,834 		29,000 +1.4% 1.55 US$44,834
2023-01-03 2022-12-29 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
7,000 +0.3%
1.54
US$10,752 		7,000 +0.3% 1.54 US$10,752
2022-12-28 2022-12-28 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
3,293 +0.2%
1.50
US$4,923 		3,293 +0.2% 1.50 US$4,923
2022-12-28 2022-12-23 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
15,707 +0.8%
1.44
US$22,665 		15,707 +0.8% 1.44 US$22,665
2022-12-22 2022-12-22 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
41,414 +2.1%
1.48
US$61,127 		41,414 +2.1% 1.48 US$61,127
2022-12-22 2022-12-22 B Purchase
3.6
Pratt Raymond Dennis

Chief Medical Officer

Officer
3,500 +2.3%
1.54
US$5,402 		3,500 +2.3% 1.54 US$5,402
2022-12-22 2022-12-20 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
3,586 +0.2%
1.48
US$5,307 		3,586 +0.2% 1.48 US$5,307
2022-12-20 2022-12-20 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
13,830 +0.7%
1.50
US$20,759 		13,830 +0.7% 1.50 US$20,759
2022-12-20 2022-12-19 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
40,719 +2.1%
1.49
US$60,834 		40,719 +2.1% 1.49 US$60,834
2022-12-20 2022-12-16 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
341 +0.0%
1.50
US$512 		341 +0.0% 1.50 US$512
2022-11-25 2022-11-23 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
4,610 +0.2%
1.44
US$6,634 		4,610 +0.2% 1.44 US$6,634
2022-11-25 2022-11-22 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
15,495 +0.8%
1.42
US$22,018 		15,495 +0.8% 1.42 US$22,018
2022-11-21 2022-11-21 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
25,005 +1.3%
1.42
US$35,532 		25,005 +1.3% 1.42 US$35,532
2022-11-21 2022-11-18 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
16,100 +0.9%
1.34
US$21,606 		16,100 +0.9% 1.34 US$21,606
2022-11-21 2022-11-17 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
8,900 +0.5%
1.27
US$11,303 		8,900 +0.5% 1.27 US$11,303
2022-09-27 2022-09-27 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
73,893 +4.1%
1.37
US$101,381 		73,893 +4.1% 1.37 US$101,381
2022-09-27 2022-09-26 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
31,107 +1.8%
1.38
US$43,052 		31,107 +1.8% 1.38 US$43,052
2022-09-27 2022-09-23 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
30,000 +1.7%
1.42
US$42,660 		30,000 +1.7% 1.42 US$42,660
2022-09-20 2022-09-20 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
600 +0.0%
1.45
US$870 		600 +0.0% 1.45 US$870
2022-09-20 2022-09-19 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
1,400 +0.1%
1.46
US$2,040 		1,400 +0.1% 1.46 US$2,040
2022-09-20 2022-09-16 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
6,000 +0.3%
1.44
US$8,652 		6,000 +0.3% 1.44 US$8,652
2022-09-08 2022-09-08 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
29,000 +1.7%
1.40
US$40,571 		29,000 +1.7% 1.40 US$40,571
2022-09-08 2022-09-07 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
2,130 +0.1%
1.39
US$2,950 		2,130 +0.1% 1.39 US$2,950
2022-09-08 2022-09-06 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
870 +0.1%
1.38
US$1,201 		870 +0.1% 1.38 US$1,201
2022-09-01 2022-09-01 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
39,768 +2.4%
1.42
US$56,471 		39,768 +2.4% 1.42 US$56,471
2022-09-01 2022-08-31 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
39,494 +2.4%
1.42
US$56,200 		39,494 +2.4% 1.42 US$56,200
2022-09-01 2022-08-30 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
20,738 +1.3%
1.41
US$29,261 		20,738 +1.3% 1.41 US$29,261
2022-06-22 2022-06-22 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
39,000 +2.5%
1.45
US$56,355 		39,000 +2.5% 1.45 US$56,355
2022-06-22 2022-06-21 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
21,094 +1.4%
1.38
US$29,110 		21,094 +1.4% 1.38 US$29,110
2022-06-22 2022-06-17 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
39,906 +2.7%
1.33
US$52,915 		39,906 +2.7% 1.33 US$52,915
2021-12-17 2021-12-17 B Purchase
3.3
Lowrance David L

CHIEF FINANCIAL OFFICER

Officer
4,000 +2.9%
1.14
US$4,569 		4,000 +2.9% 1.14 US$4,569
2021-12-17 2021-12-17 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
25,000 +1.8%
1.13
US$28,225 		25,000 +1.8% 1.13 US$28,225
2021-12-17 2021-12-15 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
15,000 +1.1%
1.08
US$16,260 		15,000 +1.1% 1.08 US$16,260
2021-12-13 2021-12-10 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
35,000 +2.5%
1.04
US$36,365 		35,000 +2.5% 1.04 US$36,365
2021-12-09 2021-12-09 B Purchase
3.1
Chowdhury Badrul A.

CHIEF MEDICAL OFFICER

Officer
25,000 +16.7%
1.05
US$26,250 		25,000 +16.7% 1.05 US$26,250
2021-12-09 2021-12-08 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
13,157 +1.0%
1.05
US$13,815 		13,157 +1.0% 1.05 US$13,815
2021-12-08 2021-12-08 B Purchase
2.8
Pauls Matthew

CHIEF EXECUTIVE OFFICER

Executive Director
6,500 +1.7%
1.06
US$6,889 		6,500 +1.7% 1.06 US$6,889
2021-12-09 2021-12-07 B Purchase
3.5
RAMSAY DAVID A
Non-Executive Director
11,843 +0.9%
1.05
US$12,400 		11,843 +0.9% 1.05 US$12,400
Explore more

More insider trading research around Savara Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America